Edition:
United States

Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

4.07USD
1:58pm EDT
Change (% chg)

$-0.02 (-0.49%)
Prev Close
$4.09
Open
$4.20
Day's High
$4.21
Day's Low
$3.94
Volume
750,352
Avg. Vol
1,899,108
52-wk High
$9.19
52-wk Low
$3.15

All Insider Trades
Trading Date Name Title Type Shares Traded Price
9 Aug 2017

Vitullo (Nicole)

Director Sell 1,714,954 $5.06
9 Aug 2017

Vitullo (Nicole)

Director Buy 20,706 $3.11
9 Aug 2017

Vitullo (Nicole)

Director Buy 2,790,539 $3.11
9 Aug 2017

Vitullo (Nicole)

Director Sell 12,726 $5.06
27 Jun 2017

Fisherman (Jason S)

Director Buy 1,500 $0.00
21 Dec 2016

Fisherman (Jason S)

Director Buy 10,000 $3.96
4 Dec 2016

Fenton (Mary Kay)

Chief Financial Officer Buy 2,500 $4.11
1 Dec 2016

Deshpande (Milind S)

Chief Executive Officer Buy 2,500 $4.06
1 Dec 2016

Truitt (Joseph)

Officer Buy 3,500 $4.06
1 Dec 2016

Barrish (Joel C)

Officer Buy 2,500 $4.06
1 Dec 2016

Manning (Martha E)

General Counsel Buy 2,500 $4.09
29 Dec 2015

Apelian (David)

Officer Buy 10,000 $3.02
29 Dec 2015

Apelian (David)

Officer Sell 10,000 $10.50
27 Dec 2015

Fenton (Mary Kay)

Chief Financial Officer Buy 43,500 $1.05
27 Dec 2015

Fenton (Mary Kay)

Chief Financial Officer Sell 43,500 $10.08
10 Nov 2015

Vitullo (Nicole)

Director Sell 49,630 $10.31
10 Nov 2015

Vitullo (Nicole)

Director Sell 370 $10.31
9 Nov 2015

Vitullo (Nicole)

Director Sell 1,325 $10.43
9 Nov 2015

Vitullo (Nicole)

Director Sell 177,749 $10.43
8 Nov 2015

Vitullo (Nicole)

Director Sell 2,375 $10.01
8 Nov 2015

Vitullo (Nicole)

Director Sell 318,551 $10.01
24 Sep 2015

Vitullo (Nicole)

Director Sell 69 $8.22
24 Sep 2015

Vitullo (Nicole)

Director Sell 9,241 $8.22

Institutional Holders

% Shares Owned: 92.65%
# of Holders: 196
Total Shares Held: 126,704,700
3 Mo. Net Change: 3,983,331
# New Positions: 20
# Closed Positions: 20
# Increased Positions: 70
# Reduced Positions: 80
# Net Buyers: -10

Officers & Directors

Name Age Since Current Position

David Scheer

63 2010 Chairman of the Board

Milind Deshpande

59 2013 President, Chief Executive Officer, Director

Mary Fenton

51 2015 Chief Financial Officer, Executive Vice President

Martha Manning

61 2016 Executive Vice President, General Counsel, Corporate Secretary

David Apelian

51 2013 Executive Vice President, Chief Medical Officer

Joseph Truitt

51 2014 Executive Vice President, Chief Commercial Officer

Amy Jennings

2016 Senior Vice President - Regulatory Affairs

Michael Kishbauch

67 2013 Director

Frank Verwiel

55 2015 Director

Jason Fisherman

58 2000 Independent Director

Gary Frashier

78 2008 Independent Director

Kurt Graves

49 2012 Independent Director

Robert Van Nostrand

60 2007 Independent Director

Nicole Vitullo

59 2010 Independent Director